CFTR and cystic fibrosis: Cysteamine is an FDA-approved drug for nephropathic cystinosis that is able to ameliorate the maturation and trafficking of the F508del-CFTR channel to the plasma membrane, thereby enhancing the autophagic activity of CF airway cells [169].